Anne Searls De Groot
Anne Searls De Groot is a physician, immunologist and entrepreneur. She is the co-founder and CEO/CSO of the immunoinformatics company EpiVax.[1][2][3]
Anne Searls De Groot | |
---|---|
Website | www |
She is actively involved in graduate teaching at the Center for Vaccines and Immunology and guides the scientific research program in her laboratory at EpiVax.[4][5][6][7]
Education
De Groot graduated from Smith College in 1978 with a BA and from the Pritzker School of Medicine at University of Chicago in 1983 with an MD. She completed her residency in internal medicine at Tufts New England Medical Center and then trained in Parasitology and Vaccine Research at the NIH and in Infectious Disease at the Tufts New England Medical Center.[8]
De Groot is board certified in Internal Medicine and Infectious Disease. She is the volunteer Medical Director and currently practices Internal Medicine at the Clinica Esperanza (Hope Clinic), a free clinic for Rhode Island residents who do not have health insurance.[9]
Career
Brown University
De Groot was a professor at Brown University, where she established the TB/HIV Research Lab. The laboratory attracted a range of intelligent and creative Brown University undergraduate and graduate students (Bill Jesdale, Gabriel Meister, Tamar Renaud, Jessica Stevens, and many others) who worked with De Groot on projects ranging from improving healthcare for inmates living in correctional facilities in the United States, improving access to care in West Africa, and developing cutting edge tools for analyzing protein sequences and designing vaccines.[10][11]
While at Brown University, De Groot worked with Gabriel Meister and Bill Jesdale to develop the EpiMer and EpiMatrix epitope mapping tools.[12] These were among the first motif-based and matrix-based, fully automated T cell epitope mapping tools.[13] The team applied these tools to HIV vaccine design, and were soon travelling to HIV Vaccine conferences as a group to demonstrate how the tools could be used to help design vaccines that would be effective against a range of HIV strains (see GAIA Vaccine, and GAIA Vaccine Foundation). Additional tools were developed that automated genome sequence analysis for highly conserved, immunogenic epitopes, starting from any protein sequence.[14]
EpiVax
De Groot and Bill Martin (COO/CIO EpiVax) founded EpiVax, with an initial grant from the Slater Biotechnology Foundation, in 1998 to use bioinformatics to design epitope-driven vaccines and expanded to offer immunogenicity screening services for protein therapeutics.[15] De Groot, Martin and Dr. Leonard Moise discovered regulatory T cell epitopes, called “Tregitopes”, that are shown to activate regulatory T cells and suppress the immune response.[16] De Groot, Martin and Moise also developed the JanusMatrix tool, that identifies regions of "immune camouflage" used by pathogens to escape immune response. EpiVax was created to establish a commercial company to make immunology tools available to a wider audience. During the 1998-2008 period, EpiVax became a well known for innovative, collaborative research in computational vaccinology and immunoinformatics.[14][17]
Yale HIV in Prison program
Between 1992 and 2008, De Groot also contributed to the Yale HIV in Prison program and Massachusetts Correctional Institution at Framingham, providing medical treatment to inmates, founded the GAIA Vaccine Foundation for improving global AIDS treatment.[18][19][20]
University of Rhode Island
De Groot was invited to establish a new Institute at the University of Rhode Island in 2008. She directed the Institute for Immunology and Informatics at the University of Rhode Island,[21] from 2009 to 2019, and is currently Senior Scientist and Professor at the University of Georgia Center for Vaccines and Immunology.[22]
Clinica Esperanza
De Groot founded a free clinic in Rhode Island, Clinica Esperanza. Her current work at the Clinica Esperanza includes the nurse-run CHEER Clinic, a walk in clinic pilot program that serves as an alternative to non-urgent ER visits.[23]
Clinica Esperanza (Hope Clinic) is a volunteer-run free clinic for uninsured adults located in the Olneyville neighborhood of Providence, Rhode Island. It provides culturally-attuned and sensitive medical care to more than 9,000 patients since its founding in 2007, 80% of whom are native Spanish speakers.[24][25]
Awards
- Eli Lilly Award, National Foundation for Infectious Diseases[26]
- Phase I Innovation Award, Slater Biomedical Foundation[26]
- Phase II Innovation Award, Slater Biomedical Foundation[26]
- Genius Award in Science and Technology of 2003, Esquire Magazine[27]
- Woman of Achievement Award, YWCA[28]
- Lifetime Achievement honor, Providence Business News’ Business Women Awards[29]
- R.I.’s Top Doctors of 2010, Providence Monthly[30]
- Smith College Medal of 2013, Smith College[2][31]
- One of the 50 most influential Vaccinologists of 2014, Vaccine Nation[32][33][34]
- Vaccinology CEO of the year, 2016[26]
- Global Health Award of 2020, AAPS[35]
References
- "About Us:EpiVax Team". EpiVax Inc. Archived from the original on 7 December 2013. Retrieved 2 December 2013.
- "Conversations with the Smith Medalists: Anne Searls De Groot '78, Scientist and Entrepreneur | Smith College". 2013-05-15. Archived from the original on 2013-05-15. Retrieved 2023-03-30.
- Davis, Marion (2009-02-12). "URI names EpiVax founder to head Institute for Immunology & Informatics". Providence Business News. Retrieved 2023-03-30.
- Noe, Amy R.; Terry, Frances E.; Schanen, Brian C.; Sassano, Emily; Hindocha, Pooja; Phares, Timothy W.; Moise, Leonard; Christen, Jayne M.; Tucker, Kenneth D.; Kotraiah, Vinayaka; Drake, Donald R.; Martin, William D.; De Groot, Anne S.; Gutierrez, Gabriel M. (2021). "Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains". Frontiers in Immunology. 12: 689920. doi:10.3389/fimmu.2021.689920. ISSN 1664-3224. PMC 8217813. PMID 34168657.
- De Groot, Anne S.; Desai, Ankit K.; Lelias, Sandra; Miah, S. M. Shahjahan; Terry, Frances E.; Khan, Sundos; Li, Cindy; Yi, John S.; Ardito, Matt; Martin, William D.; Kishnani, Priya S. (2021). "Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease". Frontiers in Immunology. 12: 636731. doi:10.3389/fimmu.2021.636731. ISSN 1664-3224. PMC 8242953. PMID 34220802.
- Kotraiah, Vinayaka; Phares, Timothy W.; Terry, Frances E.; Hindocha, Pooja; Silk, Sarah E.; Nielsen, Carolyn M.; Moise, Leonard; Tucker, Kenneth D.; Ashfield, Rebecca; Martin, William D.; De Groot, Anne S.; Draper, Simon J.; Gutierrez, Gabriel M.; Noe, Amy R. (2021). "Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization". Frontiers in Immunology. 12: 690348. doi:10.3389/fimmu.2021.690348. ISSN 1664-3224. PMC 8294059. PMID 34305923.
- Winterling, Karina; Martin, William D.; De Groot, Anne S.; Daufenbach, Jens; Kistner, Steffen; Schüttrumpf, Jörg (2021). "Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach". Journal of Thrombosis and Haemostasis: JTH. 19 (9): 2161–2170. doi:10.1111/jth.15413. ISSN 1538-7836. PMC 8456792. PMID 34060724.
- "Faculty Directory: Anne De Groot". Brown University. Retrieved 2 December 2013.
- "Clinica Esperanza: About Us: Providers". Fund Clinica Esperanza. Archived from the original on 7 December 2013. Retrieved 2 December 2013.
- "Annie De Groot proves the power of one person". Boston Herald. 2009-10-01. Retrieved 2023-03-30.
- Sanou, Missa P.; De Groot, Anne S.; Murphey-Corb, Michael; Levy, Jay A.; Yamamoto, Janet K. (2012). "HIV-1 Vaccine Trials: Evolving Concepts and Designs". The Open AIDS Journal. 6: 274–288. doi:10.2174/1874613601206010274. ISSN 1874-6136. PMC 3534440. PMID 23289052.
- Meister, G. E.; Roberts, C. G.; Berzofsky, J. A.; De Groot, A. S. (1995). "Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences". Vaccine. 13 (6): 581–591. doi:10.1016/0264-410x(94)00014-e. PMID 7483779.
- De Groot, A. S.; Knopp, P. M.; Martin, W. (2005). "De-immunization of therapeutic proteins by T-cell epitope modification". Developments in Biologicals. 122: 171–194. PMID 16375261.
- "The Marvel of Modern Technology". www.hivplusmag.com. Retrieved 2023-03-30.
- Singer, Thea (January 2001). "The Zealot: Mission Critical". Inc Magazine. Retrieved 27 November 2013.
- De Groot, Anne; Leonard Moise; William Marin (15 October 2008). "Activation of natural regulatory T cells by IgG Fc–derived peptide "Tregitopes"". Blood. 112 (8): 3301–3311. doi:10.1182/blood-2008-02-138073. PMC 2569179. PMID 18660382.
- Moise, L.; De Groot, A.; Marcello, A.; Tassone, R.; Martin, W.; Cousens, L. (2013). "Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company". Rhode Island Medical Journal. 96 (2): 19–21. PMID 23641421.
- "Good Gate: GAIA Vaccine Foundation". Goodgate. Archived from the original on 7 December 2013. Retrieved 2 December 2013.
- Archives, L. A. Times (1999-10-16). "Rules for Clinical Tests on Inmates Are Drawn Up". Los Angeles Times. Retrieved 2023-03-30.
- Springer, Sandra A.; Altice, Frederick L. (2005-12-01). "Managing HIV/AIDS in correctional settings". Current HIV/AIDS Reports. 2 (4): 165–170. doi:10.1007/s11904-005-0011-9. ISSN 1548-3576. PMID 16343373. S2CID 9989116.
- "Institute for Immunology and Informatics: About". University of Rhode Island. Archived from the original on 7 December 2013. Retrieved 2 December 2013.
- "the GAIA Vaccine Foundation: About".
- McCarthy, M.; Barry, K.; Estrada, C.; Veliz, B.; Rosales, D.; Leonard, M.; De Groot, A. S. (2021). "Recruitment, Training, and Roles of the Bilingual, Bicultural Navegantes: Developing a Specialized Workforce of Community Health Workers to Serve a Low-Income, Spanish-Speaking Population in Rhode Island". Frontiers in Public Health. 9: 666566. doi:10.3389/fpubh.2021.666566. PMC 8213204. PMID 34150707.
- "Home | CEHC". hope-clinic. Retrieved 2023-03-30.
- Eldakroury, Ahmed; Olivera, Ericka; Martin, Rebecca; De Groot, Anne S. (4 January 2013). "Adherence to American Diabetes Association guidelines in a volunteer-run free clinic for the uninsured: Better than standards achieved by clinics for insured patients". Rhode Island Medical Journal. 96 (1): 25–29. PMID 23638455.
- "URI professor, vaccine pioneer honored by University of Chicago". Retrieved 2023-03-30.
- "Biomed Rounds: Vaccine booster named an Esquire 'revolutionary'". Bizjournals. Retrieved 2023-03-30.
- epivax3 (2008-09-29). "Dr. Annie De Groot, CEO, awarded YWCA 2008 Women of Achievement Award". EpiVax, Inc. - Informatics and Immunology. Retrieved 2023-03-30.
- "Business Women Awards". Providence Business News. Retrieved 2023-03-30.
- "Top Doctors". Rhode Island Monthly. Retrieved 2023-03-30.
- "The Smith College Medal". Smith College. Retrieved 2023-03-30.
- "The Most Influential People in Vaccines" (PDF). 2014.
- "CELS Scientist Annie De Groot Named One of the 50 Most Influential People in Vaccine Industry". Retrieved 2023-03-30.
- Staff, P. B. N. (2014-09-09). "De Groot named one of most influential people in vaccine industry". Providence Business News. Retrieved 2023-03-30.
- Pharmaceutical Global Health Award, retrieved 2023-03-30